Showing results (81-90 of 329) with videos related to
Sort By:
Pageof 33
Oncoscience|February 6, 2025
Breaking point: Systemic mastocytosis manifesting as severe osteoporosisAreti Kalfoutzou, Kalliroi Spanou, Adam Mylonakis, et al.Oncoscience|October 13, 2025
Vulvar mucinous cyst mimicking common lesions with concurrent multiple bartholin cysts in a reproductive-age woman: A rare case report and review of literatureNaina Kumar, Immanuel Pradeep, Banka Sai Swetha, et al.Oncoscience|April 8, 2020
Metabolic Reprogramming by c-MET Inhibition as a Targetable Vulnerability in GlioblastomaTrang Thi Thu Nguyen, Enyuan Shang, Georg Karpel-Massler, et al.Oncoscience|September 14, 2020
Future directions of neoadjuvant therapy in pancreatic cancerCarmen Mota Reyes, Ümmügülsüm Yurteri, Helmut Friess, et al.Oncoscience|September 22, 2023
Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgeryMohamed A Gouda, Filip Janku, Neeta Somaiah, et al.Oncoscience|September 22, 2023
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcomaMohamed A Gouda, Maria A Zarzour, Ara A Vaporciyan, et al.Oncoscience|September 16, 2022
lncRNA HOTAIR functions and therapeutic perspectivesSabrina Garbo, Marco Tripodi, Cecilia BattistelliOncoscience|June 23, 2015
The DAXX co-repressor is directly recruited to active regulatory elements genome-wide to regulate autophagy programs in a model of human prostate cancerLorena A Puto, Christopher Benner, Tony HunterOncoscience|June 23, 2015
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancerIsabella Monia Montagner, Anna Merlo, Debora Carpanese, et al.Oncoscience|June 23, 2015
FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cellsLiping Zhang, Aijun Shen, Lu Wang, et al.Pageof 33